Group 1 - The core point of the article is that Debang Technology (SH 688035) held its 20th meeting of the second board session on October 24, 2025, to review proposals related to the revision and establishment of certain corporate governance systems [1] - For the fiscal year 2024, Debang Technology's revenue composition is heavily weighted towards electronic packaging materials, which account for 99.85% of total revenue, while other businesses contribute only 0.15% [1] - As of the time of reporting, Debang Technology has a market capitalization of 7.5 billion yuan [1] Group 2 - The article also highlights the booming secondary market for biopharmaceuticals in China, with overseas licensing deals reaching 80 billion USD this year, while the primary market is experiencing a fundraising slowdown [1]
德邦科技:10月24日召开董事会会议